Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostic Hybrids Inc.

Division of Quidel Corp.
www.dhiusa.com

Latest From Diagnostic Hybrids Inc.

Deals Shaping The Medical Industry, October 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Medical Device Deals Update, September 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device

Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q1 2011

For the first three months of 2011, medical device companies raised $733 million, with venture rounds bringing in $494 million. Two-thirds of the $3.9 billion in M&A activity came from Terumo's monstrous $2.6 billion cash takeover of US blood processing equipment maker CaridianBCT Holding. Buoyed by Opko Health's $105 million follow-on, the FOPO category represented almost half of the first quarter's in vitro diagnostics/research $370 million total. The stand-out IVD acquisition was Danaher's $6.8 billion takeover of publicly traded Beckman Coulter.
Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Quidel Corp.
  • Senior Management
  • David Scholl, PhD, Pres. & CEO
    Morgan Geoff, VP, CFO
    James L Brown, SVP, COO
    Paul D Olivo, MD, PhD, VP, Rsch.
  • Contact Info
  • Diagnostic Hybrids Inc.
    Phone: (740) 589-3300
    1055 East State St., Ste. 100
    Athens, OH 45701
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register